TMS Co., Ltd Logo

TMS Co., Ltd

A clinical-stage company developing medicines for diseases with high unmet needs.

4891 | T

Overview

Corporate Details

ISIN(s):
JP3544960002
LEI:
Country:
Japan
Address:
府中市府中町一丁目9番地京王府中1丁目ビル11階

Description

TMS Co., Ltd. is a clinical-stage company focused on the research, development, manufacture, and sale of drug products, quasi-drugs, and medical devices. Founded by scientists from the Tokyo University of Agriculture and Technology, the company aims to discover and develop transformative medicines for diseases with high unmet medical needs. Its research centers on a group of fungus-derived small molecule compounds known as SMTPs, which exhibit a novel dual mode of action. The company's objective is to create revolutionary drugs for conditions that currently lack effective treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-01-13 07:13
確認書
Japanese ZIP 8.0 KB
2023-01-13 07:12
四半期報告書-第19期第3四半期(2022/09/01-2022/11/30)
Japanese ZIP 119.4 KB
2022-11-14 07:00
訂正有価証券届出書(新規公開時)
Japanese ZIP 3.1 MB
2022-11-04 07:00
訂正有価証券届出書(新規公開時)
Japanese ZIP 3.0 MB
2022-10-18 08:00
有価証券届出書(新規公開時)
Japanese ZIP 6.1 MB

Automate Your Workflow. Get a real-time feed of all TMS Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TMS Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TMS Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.